by admin | Mar 6, 2026 | News & Opinions
By Will Maddox – Fierce Biotech – After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate. The agreement, announced in Beam’s...
by admin | Mar 5, 2026 | News & Opinions
by Lynda Charters – Opthamology – A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO), according to a press...
by admin | Mar 4, 2026 | News & Opinions
By Neuroscience News.com – Spinal cord injuries have long been considered permanent because neurons in the central nervous system lack the natural ability to regrow. However, researchershave developed a novel, 3D-printed implant that could change that. The study...
by admin | Mar 3, 2026 | News & Opinions
By Karen Guzman – Yale News – Yale scientists have engineered natural killer cells that eliminate solid tumors in mouse models. The study may lead to a simpler, “off the shelf” immunotherapy for hard-to-treat cancers. Since scientists first discovered that...
by admin | Mar 2, 2026 | News & Opinions
By Edward Chen – Nature – Elderly people with frailty, which affects up to one-quarter of over-50s, increased their endurance after a single dose of stem cells. A single dose of stem cells can help older people with frailty to build up their endurance, a...
